COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Actio Biosciences uses human genetics, bioinformatics, and chemistry to discover oral small-molecule therapeutics targeting ion channels (TRPV4, KCNT1), advancing programs and Phase 1 trials with academic and JAX collaborations.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
